Texas HB 3717: Relating to the establishment of a grant program to fund the United States Food and Drug Administration's drug development trials with ibogaine for the purpose of securing the administration's approval as a medication for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy.

Status: Laid on the table subject to call (as of 2025-05-12)

State: Texas · Session: 89R · Bill: HB 3717

Subjects: Alcoholism & Drug Abuse (I0030), Crimes--Drugs (I0185), HEALTH & HUMAN SERVICES COMMISSION (V0177), Health--General (I0385), MEDICINE & PRESCRIPTION DRUGS (S7338), RESEARCH & DEVELOPMENT (S0135), State Finances--Appropriations (I0746)

Sponsors: Harris, Leach, Orr, Phelan, VanDeaver, Alders, Barry, Bell, Keith, Buckley, Cain, Davis, Aicha, Garcia, Josey, Gerdes, Gámez, Hefner, LaHood, Lalani, Leo Wilson, Lopez, Janie, Lujan, McLaughlin, Metcalf, Morales Shaw, Morales, Eddie, Olcott

View Texas HB 3717 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.